To ask the Secretary of State for Health and Social Care, with reference to the NHS England press release, entitled Potential to eliminate cervical cancer in England thanks to NHS Long Term Plan, published on 20 January 2020, if he will publish which (a) technology and (b) research will be in receipt of that funding.
The introduction of the human papillomavirus (HPV) vaccination for girls, and for boys from 2019 as committed to in the NHS Long Term Plan, has reduced the incidence of cancer-causing HPV strains to below 2% in 16 to 18-year old women. Experts say that the vaccine offers the potential to eliminate cervical cancer completely.
As part of the Long Term Plan ambition to diagnose 75% more cancers at an earlier stage, the Department has funded £200 million for new equipment to drive earlier diagnosis of cancer and improve survival. More than 300 diagnostic machines will be funded across the country, replacing outdated MRI machines, CT scans and breast screening equipment with cutting edge technology.
The Department invests £1 billion per year in health research through the National Institute for Health Research, of which expenditure on cancer research was £132 million in 2018/19.